Sabra Healthcare SBRA Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Sabra Healthcare in its filing.
Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.
The official record: Sabra Healthcare’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sabra Healthcare's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sabra Healthcare's cash & equivalents?
- Sabra Healthcare (SBRA) reported cash & equivalents of $116.53M in Q1 2026.
- How has Sabra Healthcare's cash & equivalents changed year-over-year?
- Sabra Healthcare's cash & equivalents increased by 414.4% year-over-year, from $22.65M to $116.53M.
- What is the long-term trend for Sabra Healthcare's cash & equivalents?
- Over 5 years (2020 to 2025), Sabra Healthcare's cash & equivalents has grown at a 1.8% compound annual growth rate (CAGR), from $65.52M to $71.54M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.